Clinical Trials Browser

Completed × INDUSTRY × STA 9090 × Clear all

NCT01039519 2016-03-10

A Study Evaluating STA-9090 in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST)

Phase 2 Completed

27 enrolled 22 charts

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT01677455 2015-11-05

Enchant

Phase 2 Completed

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01562015 2015-05-20

CHIARA

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT01031225 2014-09-19

A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01183364 2014-09-19

A Dose Escalation Study of STA-9090 and Docetaxel in Patients With Solid Tumors

Phase 1 Completed

Neoplasms

NCT00687934 2014-09-18

Study of STA-9090, Administered Once-Weekly in Patients With Solid Tumors

Phase 1 Completed

Neoplasm Metastasis

NCT00858572 2014-09-18

STA-9090 for Treatment of AML, CML, MDS and Myeloproliferative Disorders

Phase 1 Completed

MyeloidOther hematologic neoplasm

Myeloproliferative Disorders, Hematologic Neoplasms

NCT00964873 2014-09-18

A Phase 1 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous Leukemia

Phase 1 Completed

LymphoidOther hematologic neoplasm

Blast Crisis, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma